Nishant C. Saxena, Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,600 shares at $9.63 ($25K) on 2026-08-11, disclosed to the SEC on 2026-08-12.
Open-market purchase of $25k CRBP by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.